Skip to main content
. 2016 Aug 1;95(5):1367–1377. doi: 10.1016/j.ijrobp.2016.03.031

Table 3.

Selected toxicities by grade among the 82 patients who began radiation therapy (safety population), according to trial group

Toxicity Grade Group 1 (n=35) Group 2 (n=47) Total (N=82)
Esophagitis 0 2 (6) 7 (15) 9 (11)
1 1 (3) 4 (9) 5 (6)
2 30 (86) 33 (70) 63 (77)
3 2 (6) 3 (6) 5 (6)
4 0 0 0
5 0 0 0
RTPN 0 11 (31) 24 (51) 35 (43)
1 12 (34) 10 (21) 22 (27)
2 10 (29) 12 (26) 22 (27)
3 2 (6) 1 (2) 3 (4)
4 0 0 0
5 0 0 0
All toxicities grades ≥3 25 (71) 36 (77) 61 (74)
3 20 (57) 26 (55) 46 (56)
4 3 (9) 8 (17) 11 (13)
5 2 (6) 2 (4) 4 (5)
Grade ≥3% hematologic
 White blood cell decreased 2 (6) 9 (19) 11 (13)
 Lymphocyte decreased 1 (3) 8 (17) 9 (11)
 Neutrophil decreased 4 (11) 8 (17) 12 (15)
Grade ≥3 other
 Lung infection 9 (26) 9 (19) 18 (22)
 FEV decreased 5 (14) 7 (15) 12 (15)

Abbreviation: FEV = forced expiratory volume.

Values are number (percentage).

RTPN = radiation therapy pneumonitis. Two patients received higher lung doses than allowed in the protocol. Both received prescribed tumor doses of 63 Gy, one with a lung V20 of 46.5% and one with 40.7%. Neither experienced RTPN.

Four patients had grade 5 events: in group 1, 1 patient experienced esophageal perforation and 1, hemoptysis. Two group 2 patients experienced hemoptysis.

There were no relevant hemoglobin-related events.